Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
BGI's second International Conference on Genomics in the Americas to be held in September

BGI's second International Conference on Genomics in the Americas to be held in September

Preclinical data on anti-cancer activity of BI-505 published online in Cancer Cell

Preclinical data on anti-cancer activity of BI-505 published online in Cancer Cell

TSRI scientists shed light on major toxic mechanisms of Alzheimer's disease

TSRI scientists shed light on major toxic mechanisms of Alzheimer's disease

Cellectis CanCELL cell lines enable drug positioning in cancer pathways

Cellectis CanCELL cell lines enable drug positioning in cancer pathways

Scientists demonstrate feasibility of using already-approved drugs against pathogens

Scientists demonstrate feasibility of using already-approved drugs against pathogens

GGA Software Services, Pfizer to present Indigo ELN at 2013 Bio-IT World Conference and Expo

GGA Software Services, Pfizer to present Indigo ELN at 2013 Bio-IT World Conference and Expo

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

Bayer HealthCare and German Cancer Research Center to extend strategic alliance in search of novel cancer therapeutics

Bayer HealthCare and German Cancer Research Center to extend strategic alliance in search of novel cancer therapeutics

Research sheds light on malaria-related parasite's transition from acute to chronic stage

Research sheds light on malaria-related parasite's transition from acute to chronic stage

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

UIC College of Pharmacy receives grant to train students in natural product drugs

UIC College of Pharmacy receives grant to train students in natural product drugs

Scientists develop a new way to generate induced pluripotent stem cell lines from human fibroblasts

Scientists develop a new way to generate induced pluripotent stem cell lines from human fibroblasts

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

Sanford-Burnham selects organizations to participate in Florida Translational Research Program

Sanford-Burnham selects organizations to participate in Florida Translational Research Program

Media outlets examine reaction to India's Supreme Court ruling on Novartis patent case

Media outlets examine reaction to India's Supreme Court ruling on Novartis patent case

Ensemble Therapeutics to highlight IL-17A inhibitor Ensemblin at 245th ACS National Meeting

Ensemble Therapeutics to highlight IL-17A inhibitor Ensemblin at 245th ACS National Meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.